Our data are the first showing ATF4 protein expression in a large GBM patient dataset, and are in line with a recent report showing that low ATF4 transcript levels in the NIH Rembrandt Glioma database is associated with prolonged survival33. The gene discussed is ATF4; the disease is glioma.